Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage

Translational Oncology - Tập 14 Số 7 - Trang 101095 - 2021
Nagavalli Pillalamarri1, Abdullah Abdullah2, Nicole Min Qian Pek1, Luqman Khan3, Asad Ullah3, Sriya Jonnakuti1, Mujib Ullah1,2
1Institute for Immunity and Transplantation, Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Palo Alto, CA 94304, United States
2Molecular Medicine Department of Medicine, Stanford University, CA, United States
3School of Medicine, University of California, San Francisco, CA 94158, United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ullah, 2021, Microbubbles versus extracellular vesicles as therapeutic cargo for targeting drug delivery, ACS Nano, 15, 3612, 10.1021/acsnano.0c10689

Can, 2020, The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: what to expect, Stem Cells Transl. Med., 9, 1287, 10.1002/sctm.20-0164

Rogers, 2020, Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients, J. Transl. Med., 18, 1, 10.1186/s12967-020-02380-2

Gardin, 2020, Could mesenchymal stem cell-derived exosomes be a therapeutic option for critically Ill COVID-19 patients?, J. Clin. Med., 9, 2762, 10.3390/jcm9092762

Nolte, 2016, Extracellular vesicles and viruses: are they close relatives?, Proc. Natl. Acad. Sci., 113, 9155, 10.1073/pnas.1605146113

Mardpour, 2019, Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content, J. Cell. Physiol., 234, 8249, 10.1002/jcp.27669

Kumar, 2020, Extracellular vesicles in viral replication and pathogenesis and their potential role in therapeutic intervention, Viruses, 12, 887, 10.3390/v12080887

Urbanelli, 2019, The role of extracellular vesicles in viral infection and transmission, Vaccines, 7, 102, 10.3390/vaccines7030102

Rodrigues, 2018, Role of extracellular vesicles in viral and bacterial infections: pathogenesis, diagnostics, and therapeutics, Theranostics, 8, 2709, 10.7150/thno.20576

Gutiérrez-Vázquez, 2013, Transfer of extracellular vesicles during immune cell-cell interactions, Immunol. Rev., 251, 125, 10.1111/imr.12013

Yen, 2020, Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: gleaning insights for possible use in COVID-19, Stem Cells Transl. Med., 9, 1163, 10.1002/sctm.20-0186

Rao, 2020, Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19, Med. Hypotheses, 143, 10.1016/j.mehy.2020.109845

Kavianpour, 2020, The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm, Stem Cell Res. Ther., 11, 1, 10.1186/s13287-020-01849-7

Shetty, 2020, Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia, Aging Dis, 11, 462, 10.14336/AD.2020.0301

Mousavizadeh, 2020, Genotype and phenotype of COVID-19: Their roles in pathogenesis, J Microbiol Immunol Infect

Wu, 2020, Progress and Concept for COVID-19 Vaccine Development, Biotechnol J, 15, 10.1002/biot.202000147

Machitani, 2020, RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19, Cancer Sci., 111, 3976, 10.1111/cas.14618

Laing, 2020, A dynamic COVID-19 immune signature includes associations with poor prognosis, Nat. Med., 26, 1623, 10.1038/s41591-020-1038-6

Tufan, 2020, COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs, Turk. J. Med. Sci., 50, 620, 10.3906/sag-2004-168

Ren, 2021, COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas, Cell, 184, 1895, 10.1016/j.cell.2021.01.053

Shi, 2020, COVID-19 infection: the perspectives on immune responses, Cell Death Differ, 27, 1451, 10.1038/s41418-020-0530-3

Bonifacius, 2021, COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses, Immunity, 54, 340, 10.1016/j.immuni.2021.01.008

Li, 2020, Molecular immune pathogenesis and diagnosis of COVID-19, J. Pharm. Anal., 10, 102, 10.1016/j.jpha.2020.03.001

Tay, 2020, The trinity of COVID-19: immunity, inflammation and intervention, Nat. Rev. Immunol., 20, 363, 10.1038/s41577-020-0311-8

Ullah, 2020, The pandemic of novel coronavirus disease 2019 (COVID-19): need for an immediate action, Open Access J. Biomed. Sci., 2, 301, 10.38125/OAJBS.000168

Ullah, 2020, Novel coronavirus (COVID-19) treatment options, Biomed. J. Sci. Tech. Res., 27, 20872

He, 2020, The clinical course and its correlated immune status in COVID-19 pneumonia, J. Clin. Virol., 127, 10.1016/j.jcv.2020.104361

Bolouri, 2021, The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity, J. Clin. Invest., 131, 10.1172/JCI143648

Chowdhury, 2020, Immune response in COVID-19: A review, J Infect Public Health, 13, 1619, 10.1016/j.jiph.2020.07.001

Remy, 2020, Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections, JCI Insight, 5, 10.1172/jci.insight.140329

Ragab, 2020, The COVID-19 cytokine storm; what we know so far, Front. Immunol., 11, 1446, 10.3389/fimmu.2020.01446

O'Driscoll, 2020, Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment, Drug Discov Today, 25, 1124, 10.1016/j.drudis.2020.04.022

Soy, 2020, Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment, Clin. Rheumatol., 39, 2085, 10.1007/s10067-020-05190-5

Alvarez-Jiménez, 2018, Extracellular vesicles released from Mycobacterium tuberculosis-infected neutrophils promote macrophage autophagy and decrease intracellular mycobacterial survival, Front. Immunol., 9, 272, 10.3389/fimmu.2018.00272

Tu, 2020, A review of SARS-CoV-2 and the ongoing clinical trials, Int. J. Mol. Sci., 21, 2657, 10.3390/ijms21072657

Eiro, 2020, The coronavirus pandemic (SARS-CoV-2): new problems demand new solutions, the alternative of mesenchymal (stem) stromal cells, Front. Cell Dev. Biol., 8, 645, 10.3389/fcell.2020.00645

Ma, 2020, Calming cytokine storm in pneumonia by targeted delivery of TPCA-1 using platelet-derived extracellular vesicles, Matter, 3, 287, 10.1016/j.matt.2020.05.017

Bulut, 2020, Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection, Turkish Journal of Biology, 44, 273, 10.3906/biy-2002-79

Kassem, 2020, Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis, Front Cell Dev Biol, 8, 10.3389/fcell.2020.587866

Ullah, 2020, HSP70-mediated NLRP3 inflammasome suppression underlies reversal of acute kidney injury following extracellular vesicle and focused ultrasound combination therapy, Int. J. Mol. Sci., 21, 4085, 10.3390/ijms21114085

Gholampour, 2021, Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model, J Cell Physiol, 10.1002/jcp.30291

Xia, 2020, Calming the cytokine storm in pneumonia by biomimetic nanoparticles, Matter, 3, 18, 10.1016/j.matt.2020.06.006

Park, 2019, Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10, Stem Cell Res. Ther., 10, 1, 10.1186/s13287-019-1352-4

Kumar, 2020, Repurposing antiviral protease inhibitors using extracellular vesicles for potential therapy of COVID-19, Viruses, 12, 486, 10.3390/v12050486

Jiang, 2020, Role of Extracellular Vesicles in Influenza Virus Infection, Front Cell Infect Microbiol, 10, 366, 10.3389/fcimb.2020.00366

Hu, 2021, Characteristics of SARS-CoV-2 and COVID-19, Nat Rev Microbiol, 19, 141, 10.1038/s41579-020-00459-7

Fantini, 2020, Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection, Int. J. Antimicrob. Agents, 55, 10.1016/j.ijantimicag.2020.105960

Huang, 2020, Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19, Acta Pharmacol. Sin., 41, 1141, 10.1038/s41401-020-0485-4

Premkumar, 2020, The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients, Sci Immunol, 5, 10.1126/sciimmunol.abc8413

Li, 2020, Coronavirus disease 2019 (COVID-19): current status and future perspectives, Int. J. Antimicrob. Agents, 55, 10.1016/j.ijantimicag.2020.105951

Pal, 2020, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update, Cureus, 12, e7423

Satarker, 2020, Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2, Arch Med Res, 51, 482, 10.1016/j.arcmed.2020.05.012

Monteil, 2020, Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, 181, 905, 10.1016/j.cell.2020.04.004

Walls, 2020, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, 181, 281-292 e6, 10.1016/j.cell.2020.02.058

Wu, 2020, Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China, Cell Host Microbe, 27, 325, 10.1016/j.chom.2020.02.001

Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052

Verdecchia, 2020, The pivotal link between ACE2 deficiency and SARS-CoV-2 infection, Eur J Intern Med, 76, 14, 10.1016/j.ejim.2020.04.037

Winkler, 2020, SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function, Nat. Immunol., 21, 1327, 10.1038/s41590-020-0778-2

Cao, 2020, Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations, Cell Discov., 6, 1, 10.1038/s41421-020-0147-1

Bourgonje, 2020, Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19), J. Pathol., 251, 228, 10.1002/path.5471

Inal, 2020, Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy, Clin. Sci., 134, 1301, 10.1042/CS20200623

Yaqinuddin, 2020, Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: targeting a potential IL-1β/neutrophil extracellular traps feedback loop, Med. Hypotheses, 143, 10.1016/j.mehy.2020.109906

Tallei, 2020, Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (M(pro)) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study, Scientifica (Cairo), 10.1155/2020/6307457

Wrobel, 2020, SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects, Nat. Struct. Mol. Biol., 27, 763, 10.1038/s41594-020-0468-7

Giannessi, 2020, The role of extracellular vesicles as allies of HIV, HCV and SARS viruses, Viruses, 12, 571, 10.3390/v12050571

Sabanovic, 2021, Promising extracellular vesicle-based vaccines against viruses, including SARS-CoV-2, Biology, 10, 94, 10.3390/biology10020094

Portelli, 2020, Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource, Nat. Genet., 52, 999, 10.1038/s41588-020-0693-3

Arthur, 2009, The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair, J. Cell. Physiol., 218, 237, 10.1002/jcp.21592

Ullah, 2020, Emerging role of stem cell-derived extracellular microRNAs in age-associated human diseases and in different therapies of longevity, Ageing Res. Rev., 57, 10.1016/j.arr.2019.100979

Feng, 2020, Stem cell-derived extracellular vesicles mitigate ageing-associated arterial stiffness and hypertension, J. Extracell. Vesicles, 9, 10.1080/20013078.2020.1783869

Chen, 2021, Klotho deficiency causes heart aging via impairing the Nrf2-GR pathway, Circ. Res., 128, 492, 10.1161/CIRCRESAHA.120.317348

Ullah, 2020, A novel approach to deliver therapeutic extracellular vesicles directly into the mouse kidney via its arterial blood supply, Cells, 9, 937, 10.3390/cells9040937

Ullah, 2019, Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges, Stem Cell Res. Ther., 10, 1, 10.1186/s13287-019-1468-6

Ullah, 2019, An emerging role of CD9 in stemness and chemoresistance, Oncotarget, 10, 4000, 10.18632/oncotarget.27021

Robbins, 2014, Regulation of immune responses by extracellular vesicles, Nat. Rev. Immunol., 14, 195, 10.1038/nri3622

Van der Pol, 2012, Classification, functions, and clinical relevance of extracellular vesicles, Pharmacol. Rev., 64, 676, 10.1124/pr.112.005983

Riazifar, 2017, Stem cell extracellular vesicles: extended messages of regeneration, Annu. Rev. Pharmacol. Toxicol., 57, 125, 10.1146/annurev-pharmtox-061616-030146

Bjørge, 2018, Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine–a new paradigm for tissue repair, Biomater. Sci., 6, 60, 10.1039/C7BM00479F

Zhang, 2020, Mesenchymal stem cell-derived extracellular vesicles in tissue regeneration, Cell Transplant., 29, 10.1177/0963689720908500

Gieseck, 2018, Type 2 immunity in tissue repair and fibrosis, Nat. Rev. Immunol., 18, 62, 10.1038/nri.2017.90

Liu, 2020, The role of ultrasound in enhancing mesenchymal stromal cell-based therapies, Stem Cells Transl Med, 9, 850, 10.1002/sctm.19-0391

Ullah, 2020, Reversing acute kidney injury using pulsed focused ultrasound and MSC therapy: a role for HSP-mediated PI3K/AKT signaling, Mol. Ther. Methods Clin. Dev., 17, 683, 10.1016/j.omtm.2020.03.023

Álvarez, 2018, The immunomodulatory activity of extracellular vesicles derived from endometrial mesenchymal stem cells on CD4+ T cells is partially mediated by TGFbeta, J. Tissue Eng. Regen. Med., 12, 2088

Smyth, 2013, CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function, Eur. J. Immunol., 43, 2430, 10.1002/eji.201242909

Ullah, 2020, HSP70-mediated NLRP3 inflammasome suppression underlies reversal of acute kidney injury following extracellular vesicle and focused ultrasound combination therapy, Int. J. Mol. Sci., 21, 4085, 10.3390/ijms21114085

Czystowska-Kuzmicz, 2019, Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma, Nat. Commun., 10, 1, 10.1038/s41467-019-10979-3

Shon, 2015, Severity of DSS-induced colitis is reduced in Ido1-deficient mice with down-regulation of TLR-MyD88-NF-kB transcriptional networks, Sci. Rep., 5, 1, 10.1038/srep17305

Jia, 2019, Antioxidative, anti-inflammatory and hepatoprotective effects of resveratrol on oxidative stress-induced liver damage in tilapia (Oreochromis niloticus), Comp. Biochem. Physiol. C Toxicol. Pharmacol., 215, 56, 10.1016/j.cbpc.2018.10.002

Gadanec, 2021, Can SARS-CoV-2 virus use multiple receptors to enter host cells?, Int. J. Mol. Sci., 22, 992, 10.3390/ijms22030992

Todorova, 2017, Extracellular vesicles in angiogenesis, Circ. Res., 120, 1658, 10.1161/CIRCRESAHA.117.309681

Ko, 2020, Extracellular vesicle membrane-associated proteins: emerging roles in tumor angiogenesis and anti-angiogenesis therapy resistance, Int. J. Mol. Sci., 21, 5418, 10.3390/ijms21155418

Roefs, 2020, Extracellular Vesicle-Associated Proteins in Tissue Repair, Trends Cell Biol, 30, 990, 10.1016/j.tcb.2020.09.009

Salybekov, 2018, Sonic hedgehog signaling pathway in endothelial progenitor cell biology for vascular medicine, Int. J. Mol. Sci., 19, 3040, 10.3390/ijms19103040

Fleury, 2014, Extracellular vesicles as therapeutic tools in cardiovascular diseases, Front. Immunol., 5, 370, 10.3389/fimmu.2014.00370

Martin-Medina, 2018, Increased extracellular vesicles mediate Wnt5a signaling in idiopathic pulmonary fibrosis, Am. J. Respir. Crit. Care Med., 198, 1527, 10.1164/rccm.201708-1580OC

Montaner, 2014, The role of extracellular vesicles in modulating the host immune response during parasitic infections, Front. Immunol., 5, 433, 10.3389/fimmu.2014.00433

Ullah, 2020, Clinical Relevance of RNA Editing to Early Detection of Cancer in Human, Int J Stem Cell Res Ther, 7

Kato, 2020, Extracellular vesicles mediate B cell immune response and are a potential target for cancer therapy, Cells, 9, 1518, 10.3390/cells9061518

Burrello, 2016, Stem cell-derived extracellular vesicles and immune-modulation, Front. Cell Dev. Biol., 4, 83, 10.3389/fcell.2016.00083

Seo, 2018, Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells, Nat. Commun., 9, 1, 10.1038/s41467-018-02865-1

Oba, 2019, Circulating CD3(+)HLA-DR(+) Extracellular Vesicles as a Marker for Th1/Tc1-Type Immune Responses, J Immunol Res, 2019, 10.1155/2019/6720819

Lu, 2019, CD4+ T cell-released extracellular vesicles potentiate the efficacy of the HBsAg vaccine by enhancing B cell responses, Adv. Sci., 6, 10.1002/advs.201802219

Chahar, 2018, Respiratory syncytial virus infection changes cargo composition of exosome released from airway epithelial cells, Sci. Rep., 8, 1, 10.1038/s41598-017-18672-5

Knickelbein, 2016, Modulation of immune responses by extracellular vesicles from retinal pigment epithelium, Invest. Ophthalmol. Vis. Sci., 57, 4101, 10.1167/iovs.15-18353

Shah, 2018, Extracellular vesicle-mediated long-range communication in stressed retinal pigment epithelial cell monolayers, BBA Mol. Bas. Dis., 1864, 2610, 10.1016/j.bbadis.2018.04.016

Fisher, 2018, Perspective on AMD Pathobiology: A Bioenergetic Crisis in the RPE, Invest Ophthalmol Vis Sci, 59, 41, 10.1167/iovs.18-24289

Panagiotou, 2018, Extracellular vesicles, ageing, and therapeutic interventions, Cells, 7, 110, 10.3390/cells7080110

Lucchetti, 2020, Extracellular vesicles and cancer: a focus on metabolism, cytokines, and immunity, Cancers (Basel), 12, 171, 10.3390/cancers12010171

Zheng, 2014, An unbalanced PD-L1/CD86 ratio in CD14++ CD16+ monocytes is correlated with HCV viremia during chronic HCV infection, Cell. Mol. Immunol., 11, 294, 10.1038/cmi.2013.70

Barnes, 2020, Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles, Front Immunol, 11, 1040, 10.3389/fimmu.2020.01040

Szabó, 2014, Critical role of extracellular vesicles in modulating the cellular effects of cytokines, Cell. Mol. Life Sci., 71, 4055, 10.1007/s00018-014-1618-z

Fitzgerald, 2018, A system of cytokines encapsulated in extracellular vesicles, Sci. Rep., 8, 1, 10.1038/s41598-018-27190-x

Zhou, 2020, The function and clinical application of extracellular vesicles in innate immune regulation, Cell. Mol. Immunol., 17, 323, 10.1038/s41423-020-0391-1

Chen, 2019, Impact of extracellular vesicles on innate immunity, Curr. Opin. Organ Transplant., 24, 670, 10.1097/MOT.0000000000000701

Kouwaki, 2017, Extracellular vesicles deliver host and virus RNA and regulate innate immune response, Int. J. Mol. Sci., 18, 666, 10.3390/ijms18030666

Armstrong, 2017, Re-engineering extracellular vesicles as smart nanoscale therapeutics, ACS Nano, 11, 69, 10.1021/acsnano.6b07607

Buzas, 2014, Emerging role of extracellular vesicles in inflammatory diseases, Nat. Rev. Rheumatol., 10, 356, 10.1038/nrrheum.2014.19

Harting, 2018, Inflammation-stimulated mesenchymal stromal cell-derived extracellular vesicles attenuate inflammation, Stem Cells, 36, 79, 10.1002/stem.2730

Robbins, 2016, Regulation of chronic inflammatory and immune processes by extracellular vesicles, J. Clin. Invest., 126, 1173, 10.1172/JCI81131

Wahlund, 2017, Pulmonary extracellular vesicles as mediators of local and systemic inflammation, Front. Cell Dev. Biol., 5, 39, 10.3389/fcell.2017.00039

Ullah, 2020, Clinical applications of RNA editing technology for the early detection of cancer and future directions, Technol. Cancer Res. Treat., 19, 10.1177/1533033820964194

Ullah, 2020, Applications of artificial intelligence in, early detection of cancer, clinical diagnosis and personalized medicine, Artif. Intell. Cancer, 1, 39, 10.35713/aic.v1.i2.39

Oggero, 2019, The contrasting role of extracellular vesicles in vascular inflammation and tissue repair, Front. Pharmacol., 10, 1479, 10.3389/fphar.2019.01479

Khan, 2020, COVID-19 pandemic: Mechanistic approaches and gender vulnerabilities, Saudi Pharm J, 28, 1874, 10.1016/j.jsps.2020.11.014

Ullah, 2020, Clinical applications of RNA editing technology for the early detection of cancer and future directions, Technol. Cancer Res. Treat., 19, 10.1177/1533033820964194

Ullah, 2020, Need for Specialized Therapeutic Stem Cells Banks Equipped with Tumor Regression Enzymes and Anti-Tumor Genes, J Biomed Allied Res, 2

Ullah, 2018, Induced Pluripotent Stem Cells (iPS)-Derived Extracellular Vesicles Improves Immune Dysfunction and Attenuates Splenomegaly in Aged Mice, The FASEB Journal, 32, 10.1096/fasebj.2018.32.1_supplement.753.6

Ullah, 2019, Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges, Stem Cell Res. Ther., 10, 347, 10.1186/s13287-019-1468-6

Lener, 2015, Applying extracellular vesicles based therapeutics in clinical trials–an ISEV position paper, J. Extracell. Vesicles, 4, 30087, 10.3402/jev.v4.30087